TEVA PHARMACEUTICAL-SP ADR (TEVA) Stock Institutional Trading Activity


TEVA PHARMACEUTICAL-SP ADR (TEVA) position changes reported by tracked institutional filers across multiple SEC 13F reporting periods. Based on recent SEC 13F filings (Q3 2025), investors with some of the largest reported share count changes include Viking Global Investors, Renaissance Technologies LLC, Sound Shore Management, Sequoia Financial Advisors, and ARK Invest. Explore insights into buying and selling patterns, position changes, and investment conviction levels to understand institutional trading behavior and market dynamics.

Explore more:

Portfolio quarterNameTypeQuantityRemainingReported stock balance
Q2 2018Miller Value PartnersBuy393,6402,588,612$62,955
Q2 2018Berkshire HathawayBuy2,709,58543,249,295$1,051,823
Q2 2018ARK InvestBuy2,56130,487$741
Q1 2018Renaissance Technologies LLCSell-3,916,800900,963$15,397
Q1 2018Miller Value PartnersBuy1,678,8602,194,972$37,512
Q1 2018Berkshire HathawayBuy21,663,98940,539,710$692,824
Q1 2018ARK InvestBuy10,76227,926$477
Q4 2017Chou Associates ManagementSell-490,00015,000$284
Q4 2017Miller Value PartnersBuy516,112516,112$9,780
Q4 2017Berkshire HathawayBuy18,875,72118,875,721$357,695
Q4 2017Abrams Capital ManagementSell-1,880,76319,743,123$374,132
Q4 2017ARK InvestBuy17,16417,164$325
Q3 2017Muhlenkamp & CoSell-105,805700$12
Q3 2017Abrams Capital ManagementBuy19,062,61721,623,886$380,580
Q2 2017Muhlenkamp & CoBuy1,378106,505$3,538
Q2 2017Chou Associates ManagementBuy290,000505,000$16,839
Q1 2017Muhlenkamp & CoSell-134,762105,127$3,374
Q1 2017Chou Associates ManagementBuy215,000215,000$6,899
Q1 2017Appaloosa ManagementSell-2,878,0002,175,000$69,796
Q1 2017Renaissance Technologies LLCBuy2,651,9004,817,763$154,602
Q4 2016Muhlenkamp & CoBuy64,119239,889$8,696
Q4 2016Renaissance Technologies LLCBuy217,9002,165,863$78,513
Q4 2016Appaloosa ManagementBuy5,053,0005,053,000$183,171
Q4 2016Matrix Advisors Value FundBuy1,742261,000$9,461
Q3 2016Muhlenkamp & CoSell-885175,770$8,087
Q3 2016Renaissance Technologies LLCBuy560,2001,947,963$89,626
Q3 2016Viking Global InvestorsSell-8,052,43619,684,219$905,671
Q3 2016Matrix Advisors Value FundBuy23,786259,258$11,928
Q2 2016Muhlenkamp & CoSell-505176,655$8,873
Q2 2016First Eagle U.S. ValueSell-1,915,460200$10

Frequently asked questions about TEVA activity

  • Which institutional owners are buying TEVA?

    Institutional owners buying TEVA include investors who have either initiated new positions or increased their existing holdings based on recent SEC 13F filings. The activity table above highlights which funds added shares in the latest reporting periods and how their positions changed over time.

  • What does "buy" mean in TEVA activity?

    "Buy" means an investor increased their reported position in TEVA compared to the prior reporting period. This reflects growing exposure to TEVA PHARMACEUTICAL-SP ADR (TEVA) rather than necessarily a brand-new position (though new positions also appear as buys when prior quantity was zero).

  • Is institutional interest in TEVA increasing?

    Institutional interest in TEVA can be assessed by comparing the number of tracked funds adding or increasing positions versus those trimming or exiting across the periods shown. A higher number of additions typically signals increasing participation among large filers, but it should be read alongside position sizes and the full table.